Related Experiment Video
Updated: Sep 14, 2025

A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
Using continuous reinforcement learning to obtain optimal dose of the drug in patients with melanoma during initial
Elnaz Kalhor1, Amin Noori1, Sara Saboori Rad2
1Faculty of Electrical and Biomedical Engineering, Sadjad University, Mashhad, Iran.
Abstract:
The most important issue, which is met in this paper is quick treatment of melanoma. Medically, melanoma is known as one of the most malignant types of cancers. This disease can put the patients in the risk of death, if no quick action is taken. Mostly, medical experts tolerate serious challenges to determine the optimal dose. Intelligent methods can pave this way and efficiently assist them to reliably provide the best suitable dose for quick treatment. The RL approach seems to be one of the best candidates. But, the conventional RL lacks of high accuracy and speed, due to discrete states and actions and may result in increased control effort. These drawbacks have directed us to adopt the continuous RL, a combination of NNs and the RL approach. This has increased the accuracy and optimality of the dose in a continuous state space to control and annihilate the population of cancer cells, while the complexity of the approach is significantly low. According to physicians, treatment of melanoma in its initial stage takes two months. After this period, cancer cells will be completely eliminated in the patient's body. Accordingly, a mathematical model of a patient with melanoma in initial stage is employed. The proposed method is analyzed using the Eligibility Traces algorithm, Q-learning algorithm and constant-dose injection method. The simulation results have indicated that when the combination of RL approach and NNs is adopted, after 50 days, the cancer cells will completely vanish. Besides, other parameters of the considered model will be within their normal range. However, when the Eligibility Traces and Q-learning algorithm is employed, after 50 days, cancer cells will be still present in the patient's body. When the proposed hybrid method is used, the injected dose is significantly lower than that of other methods. As a consequence, the side effects of the drug will be reduced. Finally, in this result, the effectiveness of the proposed approach is evaluated in 5 melanoma patients, under the presence of uncertainty and noise. The obtained results have confirmed the promising capability of the adopted approach to control the population of cancer cells and reach a desired level.
Related Concept Videos
Rational Dosage Regimen: Maintenance Dose and Loading Dose
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
Dosage Regimen: Fixed Dose
Fixed-dose regimens can be used for various routes of administration, including intravenous (IV) injections and oral medications. For IV administration, a predetermined amount of the drug is...
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Drug Dosage Regimen: Overview
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...

